Live Event

Beyond Supplements: Next-generation smart bio-functional nutrition platforms that activate cell repair and regeneration

March 16, 2026 02:00 PM (London)

Senem Simsek

CoFounder, Principal Scientist & Scientific Technology Strategist, RnevoX Turkey

Zara Puckrin

Marketing Manager, Bitesize Bio

Current nutraceuticals rely largely on synthetic, single-target supplements with limited bioavailability, short-lived effects, and poor scalability. This webinar is for scientists, biotech founders, and innovation leaders interested in next-generation functional bio-food technologies that work with the body’s own regenerative and metabolic systems rather than overriding them. Drawing on real-world platform development, the session introduces a biologically intelligent, exosome- and non-coding RNA/epigenetic -inspired approach to functional nutrition. Attendees will gain a clear framework for evaluating and designing sustainable, scalable, and human-relevant bio-functional nutrition technologies.

 

In this webinar, you will:

  • Understand why traditional vitamin- and supplement-based systems fail in terms of bioavailability, sustainability, scalability, and long-term physiological impact — and what criteria define a next-generation bio-functional nutrition platform.

  • Learn how biologically intelligent carriers (e.g. exosome- and RNA-inspired systems) can activate endogenous repair, metabolic balance, and regenerative pathways rather than relying on external loading of nutrients.

  • Apply a practical evaluation framework to assess functional bio-food and nutraceutical technologies, distinguishing true platform innovation from rebranded supplements or short-term wellness products. This session is designed for advanced scientific and industry professionals involved in building, evaluating, and scaling biological technology platforms.

 

Connect with Senem on LinkedIn to find out more.

All emails contain an unsubscribe link.You can review our privacy policy, cookie policy and terms and conditions online.